The new Trump administration should seize the opportunity to change the Medicare drug price negotiation program by ...

CMS said it is considering ways to bring "greater transparency" to the Medicare drug pricing negotiation program mandated ...

The work of the Innovation Center has benefited from continuity across administrations; the path to further expanding value-based care and building a health system that works for people and providers ...

Teva Pharmaceuticals is suing the Centers for Medicare & Medicaid Services (CMS) for its implementation of the drug price ...